The legacy of Viagra and the pharmaceutical industry presents a challenging picture for potential investors. Initially, copyright's blockbuster drug altered the treatment of erectile dysfunction, generating substantial profits and shaping the contemporary pharmaceutical landscape. However, intellectual property expiration and the rise of off-brand